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de Cushing sob a perspectiva Bayesiana
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ABSTRACT
Objective: To estimate the pretest probability of Cushing’s syndrome (CS) diagnosis by a Bayes-
ian approach using intuitive clinical judgment. Materials and methods: Physicians were request-
ed, in seven endocrinology meetings, to answer three questions: “Based on your personal ex-
pertise, after obtaining clinical history and physical examination, without using laboratorial tests, 
what is your probability of diagnosing Cushing’s Syndrome?”; “For how long have you been 
practicing Endocrinology?”; and “Where do you work?”. A Bayesian beta regression, using the 
WinBugs software was employed. Results: We obtained 294 questionnaires. The mean pretest 
probability of CS diagnosis was 51.6% (95%CI: 48.7-54.3). The probability was directly related to 
experience in endocrinology, but not with the place of work. Conclusion: Pretest probability of 
CS diagnosis was estimated using a Bayesian methodology. Although pretest likelihood can be 
context-dependent, experience based on years of practice may help the practitioner to diagnosis 
CS. Arq Bras Endocrinol Metab. 2012;56(9):633-7
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RESUMO
Objetivo: Estimar a probabilidade pré-teste do diagnóstico de síndrome de Cushing (SC) por 
meio de julgamento clínico utilizando abordagem Bayesiana. Materiais e métodos: Médicos res-
ponderam a três perguntas, em sete congressos de endocrinologia. Após obtenção da história 
clínica/exame físico, sem exames laboratoriais, apenas com base em sua experiência pessoal, 
qual a probabilidade de diagnosticar SC?; Há quanto tempo você pratica endocrinologia?; Onde 
você trabalha? Uma regressão beta Bayesiana, utilizando o software WinBugs, foi empregada. 
Resultados: Foram obtidos 294 questionários. A estimativa Bayesiana da probabilidade média 
de diagnosticar SC foi 51,6% (IC 95%: 48,7-54,3). Houve relação direta entre probabilidade de 
diagnosticar SC e experiência da prática endócrina, porém não com o local de trabalho. Con-
clusão: A probabilidade pré-teste do diagnóstico de SC foi estimada utilizando uma metodologia 
Bayesiana. Embora a probabilidade pré-teste possa ser dependente do contexto, a experiência 
de anos de prática pode auxiliar no diagnóstico intuitivo da CS. Arq Bras Endocrinol Metab. 2012;56(9):633-7
Descritores
Síndrome de Cushing; teorema de Bayes; probabilidade pré-teste
1 Division of Endocrinology,
Department of Medicine, School of
Medicine of Ribeirao Preto,
University of Sao Paulo (FMRP-
USP), Ribeirao Preto, SP, Brazil
2 Division of Statistics, Department
of Social Medicine, FMRP-USP,
Ribeirao Preto, SP, Brazil
Correspondence to:
Ayrton C. Moreira 
Departamento de Medicina,
Faculdade de Medicina de Ribeirão 
Preto, Universidade de São Paulo,
14049-900 – Ribeirão Preto, SP, Brazil
acmoreir@fmrp.usp.br
Received on May/14/2012
Accepted on Sept/29/2012
INTRODUCTION
The diagnosis of Cushing’s syndrome (CS) still presents challenges. Once the clinical practitioner 
or endocrinologist suspects CS diagnosis, endogenous 
hypercortisolism must be confirmed using biochemical 
tests (1-3). These tests are based on the demonstration 
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of excessive cortisol secretion, loss of the circadian 
rhythm, and abnormal feedback regulation of the hy-
pothalamic-pituitary-adrenal (HPA) axis. Tests currently 
used to screen for CS are measurement of free cortisol 
in 24-hour urine (UFC), assessment of cortisol circadian 
rhythm using late-night serum and salivary cortisol le-
vels (LNSF), and cortisol suppressibility by low doses of 
dexamethasone (1 mg-DST) (4). Recently, Elamin and 
cols. conducted a systematic review and meta-analysis to 
summarize the accuracy of these tests in CS diagnosis 
(5). UFC, LNSF, and 1 mg-DST showed similarly high 
accuracy when analyzed by classical statistical methods. 
The Bayesian approach provides a kind of probabi-
listic reasoning where the probability of occurrence of 
an event is obtained conditionally on the knowledge 
of the occurrence of an earlier event (6,7). Thus, the 
Bayesian approach basically consists of three steps: (a) 
determining a prior estimate of the parameter of inter-
est based on former knowledge and previous experien-
ces; (b) finding an appropriate likelihood function or a 
mathematical expression that describes the distribution 
of the observed data; and (c) combining the prior dis-
tribution with the likelihood function using the Bayes’ 
theorem, providing the posterior distribution of the 
parameter. The likelihood ratio (LR) has been used as 
part of a Fagan nomogram that offers a graphic solu-
tion to the Bayes’ rules (8). This nomogram integrates 
the pre- with posttest probabilities, enabling clinicians 
to estimate the posttest probability of a disease.  
The difficulties in estimating pretest probabilities of 
CS are derived from the rarity of endogenous CS, and 
from the overlap in clinical findings between CS and 
other common disorders in the population, classified 
as pseudo-Cushing. The availability of clinical data and 
the subjective clinical judgment information, which 
mean the pretest probability, may enable us to estimate 
the posttest probability of CS diagnosis (9). There are 
few descriptions of pretest probability in the diagnosis 
of CS (10-12). According to the Bayesian approach, 
which considers that previous knowledge regarding 
any event may constitute the prior probability of occur-
rence, in the present study, we used clinical judgment 
and endocrine expertise of physicians in an attempt to 
estimate the pretest probability of CS diagnosis.  
MATERIAlS AND METhODS
Physicians were requested to answer a questionnaire in 
a voluntary and anonymous basis, during seven differ-
ent endocrinology meetings in the following countries: 
Brazil (Post-Endo-2008, Salvador, BA, in 2008; V 
Endo-Amazon, São Luis, MA, in 2008; VIII Meeting 
on Endocrinology, Franca, SP, in 2009; Brazilian Soci-
ety of Endocrinology and Metabolism Meeting, Belo 
Horizonte, MG, in 2009); Colombia (10th Colombian 
Congress of Endocrinology, Bucaramanga, Colombia, 
in 2009); Italy (1st ENEA Workshop: Novel Insights in 
the management of Cushing’s syndrome, Napoli, Italy, 
in 2009), and USA (Symposium: The challenges of 
Cushing’s disease diagnosis and treatment: The Latin 
America perspective, San Diego, CA, in 2010). 
The questionnaire with three questions was availa-
ble in Portuguese, Spanish or English according to the 
official language of the meetings, as shown in English 
in figure 1. This study was approved by the Ethics 
Committee for Research of the University Hospital of 
School of Medicine Ribeirao Preto. 
Figure 1. Questionnaire provided to physicians on different endocrinology 
meetings (English version). 
Would you please ll up the following questionnaire about
Cushing’s Syndrome Diagnosis
Thank you
Please, keep anonymity
1) Based on your personal expertise, after obtaining the clinical history
  and performing the clinical examination, without using laboratory tests, 
 what is your probability (expressed in percentage) of diagnosing 
 Cushing’s syndrome?
 On the scale below mark with an X the percentage that expresses your answer.
2) How long have you been practicing clinical endocrinology? (Include years of 
medical residency)
3) Where do you work? (you may indicate more than one answer)
 Primary and Secondary Healthcare Units
 Private Medical Ofce
 Public General Hospital
 Private Hospital
 University Hospital
0 20 40 60 80 100
Percentage (%)
A Bayesian beta regression (13) was used to inves-
tigate the relationship between the probability of diag-
nosing CS and a set of independent variables, such as 
experience in endocrinology, evaluated by the number 
of years of practice, professional activity, evaluated by 
the place of work in the Healthcare system, and the 
city of the meeting. Beta regression is a Bayesian hie-
rarchical model applied to continuous data with sample 
space restricted to the interval (0, 1). Data were mode-
led using beta distributions with mean probability of 
CS diagnosis that depended on covariates by means of 
a logit link function. The analysis was carried out in the 
software WinBugs (version 1.4.3, MRC, Cambridge, 
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UK) based on Markov chain Monte Carlo (MCMC) 
estimation. Summaries for each parameter of interest 
are presented as the mean of the respective simulated 
chain and its 95% credible intervals (95% CI).
RESUlTS 
A total of 294 complete questionnaires were obtained. 
Bayesian estimates of the mean probability of diagnos-
ing CS and its 95% credible intervals (95% CI) in each 
meeting are shown in table 1. The overall mean was es-
timated as 0.5161 (95% CI: 0.4878-0.5436; Figure 2). 
tained by this approach have, theoretically, a sigmoidal 
shape. However, in figure 3 we show only part of these 
curves corresponding to the interval from zero to forty 
years of endocrinology practice. Thus, in this interval, 
these curves are linear and represent a direct relation-
ship between the probabilities of CS diagnosis with the 
experience in endocrinology, evaluated by the num-
ber of years of physician practice, independent of the 
meeting. It may also be observed that a shorter time of 
experience in endocrinology led to greater differences 
between the curves obtained during the different meet-
ings, but these differences decreased with longer expe-
rience. In addition, there were no differences among 
physicians working in primary, secondary or tertiary 
healthcare, or in private or public hospitals. 
Table 1. Estimated mean probability of diagnosing Cushing’s syndrome
City of the 
meeting n
Estimated mean 
probability of 
diagnosis
95% CI
Salvador 101 0.4746 0.4279 0.5201
São Luiz 19 0.6334 0.5197 0.7359
Franca 17 0.6110 0.4922 0.7174
Belo Horizonte 30 0.4989 0.4060 0.5878
Bucaramanga 34 0.3725 0.3100 0.4344
Napoli 61 0.6249 0.5598 0.6871
San Diego 32 0.5973 0.5353 0.6583
Overall 294 0.5161 0.4878 0.5436
n: number of questionnaires; CI: credible intervals. 
Figure 2. Histogram of the overall probability of diagnosing Cushing’s 
syndrome.  
The curves presented in figure 3 describe the rela-
tionship between the years of clinical experience and 
the probability of diagnosing CS, according to each en-
docrinology meeting. These curves were obtained by a 
beta regression model with interaction terms, consider-
ing the changing values of CS diagnosis probabilities as 
a function of the time of experience in endocrinology 
and represented by a logit function. The curves ob-
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Figure 3. Fitted curves for the probabilities of diagnosing Cushing’s 
syndrome as a function of time of clinical experience, considering the 
different endocrinology meetings.
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DISCUSSION
In the present study, we applied a Bayesian approach to 
estimate the probability of CS diagnosis derived from 
self-reported clinical expertise. Considering all centers, 
the overall results show that clinicians are able to recog-
nize CS in half of the patients on clinical grounds before 
the confirmation with biochemical tests. A linear increa-
se in the probability of detecting CS was observed with 
the years of practice of the endocrinology physician.
The three first-line tests commonly used for CS 
screening are based on different physiopathological 
characteristics of the HPA axis (3-5). They are com-
plementary because none of the tests has proven to 
be fully capable of distinguishing all cases of CS from 
pseudo-Cushing states. Elamin and cols. (5) summa-
rized the sensitivities and specificities for these tests us-
ing the likelihood ratio (LR) of these tests in a Fagan 
nomogram. Although the LRs offer some advantages, 
Cushing’s syndrome diagnosis: a Bayesian approach
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they derive from sensitivity and specificity, which are 
operating characteristics of the test. The most useful 
advantage of LRs is their easy application to estimate 
the posttest probability based on the pretest probability 
of CS. In addition, the rates of false-negative and false-
positive test results depend not only on sensitivity and 
specificity of the test, but also on the prior probability 
that the subject has CS. Without any additional infor-
mation, the pretest probability is equal to the preva-
lence of the disease (14,15), and this may be true for a 
disease with high prevalence. However, it is not appli-
cable in the case of rare endogenous CS, which besides 
the overlapping of some clinical findings with more 
prevalent disorders, has little accurate epidemiological 
information. Depending on the studied population, CS 
estimated incidence is about 0.7-2.4 per million inhab-
itants per year (16,17). Therefore, in the case of rare 
diseases, in which pretest probability is uncertain, the 
Bayesian approach may be useful.
In the last five decades, three previous reports (10-
12) calculated the posttest probability of CS using 
Bayes’ theorem; two of them assumed the prevalence 
of CS as 5 to 7 per million to elicit pretest odds of the 
disease (10,11). Nugent and cols. (12), using the inci-
dence of clinical signs of CS and non-steroid laboratory 
data, concluded that a trustworthy diagnosis could be 
carried out in half of the patients. Coincidently, in the 
present study, applying a Bayesian approach to clinical 
judgment, the overall mean of pretest probability of CS 
diagnosis was 51.6% (48.8-54.4%). However, different 
from previous reports, our data are more intuitive and 
based on self-reported clinical experience. Of note, in 
the Bayesian approach, the veracity of the results is af-
fected by the goodness of the prior distribution. This, 
in turn, is dependent on the previous experience of 
one or different researchers, who can easily reach quite 
distinct conclusions, according to their accumulated 
knowledge and practices. Indeed, the choice of pre-
test probabilities in clinical settings may be inaccurate 
and vary widely (18-20). However, this uncertainty in 
pretest probability represents no obstacle for clinicians, 
once they use their intuition based on their experience, 
as they are natural Bayesians (6,14). 
Our data showed a positive relationship between 
experience in clinical endocrinology and the probabili-
ty of diagnosing CS, independent of the meeting. In 
addition, we observed that a short time of experience 
in endocrinology led to greater differences between 
the curves obtained during the different meetings, but 
these differences decreased with longer experience. In 
our opinion, these observations provide evidence that 
it is possible to incorporate prior clinical judgment, a 
consequence of previous experience in endocrinology, 
to provide pretest inferences on CS diagnosis. There-
fore, Bayesian reasoning may numerically express this 
intuitive and probabilistic mechanism of thought. In 
addition, prior clinical suspicion can be incorporated on 
pretest assessment to minimize the uncertainty of pre-
test estimation of CS diagnosis, thus facilitating the in-
terpretation of laboratory tests. In addition, our results 
may not necessarily apply to general clinical practice, 
once this is a selective study in endocrinology meetings, 
some of them attended by seasoned endocrinologists. 
Finally, pretest probability varies, when focusing on an 
individual patient, concerning the severity of clinical 
features of the same disease and the intuitive experience 
of the same physician. Thus, the physician may have a 
range of pretest probabilities, instead of a single one.
In conclusion, our study, using a formal Bayesian 
methodology, presented the numeric expression of in-
tuitive clinical estimation of pretest probability of CS 
diagnosis, whose mean is estimated in 51%. In addition, 
there is a direct relationship between the probabilities 
of the CS diagnosis and the experience in endocrinol-
ogy, evaluated by years of practice. Therefore, pretest 
likelihoods may be context-dependent.
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